Skip to main content
TipRanks
Go Ultimate75% OFF

Suven Pharmaceuticals Ltd. (COHANCE) Revenue

3 Followers

Suven Pharmaceuticals Ltd. Revenue

Suven Pharmaceuticals Ltd. had a revenue of 4.77B in the quarter ending Sep 30, 2026, with 12.88%. This bring the company's revenue in the last twelve months to 20.63B, Decreased 3.69%. In the fiscal year ending Mar 31, 2026, Suven Pharmaceuticals Ltd. had annual revenue of 22.69B with 89.43% growth.

Revenue (ttm)
20.63B
Revenue Growth
13.70%
P/S Ratio
7.62
Revenue/Employee
INR 19,015,507
Employees
1,193
Market Cap
INR 172.80B

Revenue Chart

Suven Pharmaceuticals Ltd. Revenue - Annual

05B10B15B20B25B9.07B8.34B10.10B13.20B13.40B10.51B11.98B22.69B20192020202120222023202420252026
Revenue History
Download to Excel
IN:COHANCE revenue history
Fiscal End DateRevenueChangeGrowth
Mar 31, 202622.69B10.71B89.43%
Mar 31, 202511.98B1.46B13.91%
Mar 31, 202410.51B-2.89B-21.56%
Mar 31, 202313.40B201.07M1.52%
Mar 31, 202213.20B3.11B30.75%
Mar 31, 202110.10B1.76B21.10%
Mar 31, 20208.34B-730.13M-8.05%
Mar 31, 20199.07B――
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Related stocks
CompanyRevenue
IN:COHANCE20.63B
IN:GRANULES58.83B
IN:JUBLPHARMA86.08B
IN:LAURUSLABS78.23B
IN:NEULANDLAB23.07B
IN:SOLARA15.35B